diannexin
Recombinant proteinexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Feb 1, 2008 (NCT00615966)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Annexin A5Supplementation
ANXA5 supplementation
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2364643 ↗
Also known as
- asp8597
- asp8597
- dianexin
- diannexin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01442337 | Phase 2/Phase 3 (Phase 3) | Dec 1, 2011 | Astellas |
| NCT00615966 | Phase 2 | Feb 1, 2008 | CTI Clinical Trial and Consulting Services, Emory University, PPD |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Astellas | For profit | 1 | 1 | 1 | 2011 |
| CTI Clinical Trial and Consulting Services | For profit | 1 | 0 | 1 | 2008 |
| Emory University | Academic/Hospital | 1 | 0 | 1 | 2008 |
| PPD | For profit | 1 | 1 | 1 | 2008 |
4 organizations
Page 1 / 1